Evaluation of research quality in the ALF regions

The Swedish Research Council has been tasked to evaluate the quality of the clinical research conducted in the seven regions covered by the ALF agreement.

The 2021 evaluation has been postponed due to the corona pandemic

The evaluation is conducted every fourth year, which means that the next evaluation should have been done in 2021. Because of the great strain placed on health and medical care due to the corona pandemic, we have postponed the evaluation by one year.

The ALF agreement states that 20 per cent of the ALF funding for clinical research shall be allocated on the basis of research quality. The allocation of the funding is based on the Swedish Research Council’s evaluation of the quality of clinical research conducted in the ALF regions, and the resource allocation model produced by the national ALF steering committee

In this context, and according to Clause 7 of the ALF agreement, clinical research is defined as “research that requires access to the structures and resources of the health services, and for which the aim is to solve a health problem, or identify factors that lead to improved healthsuch research as assumes the structures and resources of healthcare, and has the goal of solving an ill health problem, or identifying factors that lead to increased health”.

Three aspects of quality are evaluated:

  1. The quality of the scientific output
  2. The clinical significance and societal impact of the clinical research
  3. The prerequisites for clinical research

In addition to forming the basis for the allocation of 20 per cent of the ALF funding, the evaluation aims to identify, highlight and reward good examples in the regions that stand out nationally through their quality work. These regions can then serve as examples to other regions. The long-term goal is to raise the quality of all Swedish clinical research.


How the evaluation is done

Three panels with international members evaluate and assess the documentation sent in by the ALF regions. The contents and grounds for assessment are decided by the Swedish Research Council, based on the starting points produced by the national ALF steering committee. The starting points of the steering committee are as follows:

1. The quality of the scientific output

2. The clinical significance and societal impact of the clinical research

3. The prerequisites for clinical research

PublISHED ON 21 August 2020

UpDATED ON 21 August 2020

MORE WITHIN THE SAME SUBJECT AREA

  1. ALF funds for 2020 can be used next year too

    The coronavirus pandemic has affected the ability of the ALF regions to conduct clinical research. The Government is now making an addition to the ALF agreement, so that the regions can use their 2020 funds also during 2021.

  2. 260 ethically approved COVID-19 studies in Sweden so far

    Since the pandemic begun this spring, 260 clinical studies relating to COVID-19 have been approved by the Swedish Ethical Review Authority. Getting results from most of these studies will take time, and for several studies it might be a challenge to ...

  3. How to improve the Swedish Research Council’s work in clinical research

    Currently, the Swedish Research Council has two committees for clinical research. At the Government’s request, we have now reviewed the committees and drawn up recommendations for how the work can be developed. Two of our proposals are to close down ...